Article info
PDFArrhythmias and sudden death
Original research article
Effect of apixaban compared with warfarin on coagulation markers in atrial fibrillation
- Correspondence to Dr Christina Christersson, Department of Medical Sciences, Cardiology, Uppsala University, Uppsala SE-751 85, Sweden; christina.christersson{at}medsci.uu.se
Citation
Effect of apixaban compared with warfarin on coagulation markers in atrial fibrillation
Publication history
- Received March 27, 2018
- Revised July 13, 2018
- Accepted August 2, 2018
- First published September 12, 2018.
Online issue publication
January 15, 2019
Article Versions
- Previous version (12 September 2018).
- Previous version (9 October 2018).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.